NORTHERN TRUST CORP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,960,832
-56.6%
629,778
-0.9%
0.00%
-50.0%
Q2 2023$29,871,947
+19.6%
635,303
+6.7%
0.01%
+20.0%
Q1 2023$24,984,328
+8.1%
595,432
-1.7%
0.01%0.0%
Q4 2022$23,106,165
-2.7%
605,825
-0.1%
0.01%0.0%
Q3 2022$23,739,000
+21.7%
606,216
+0.4%
0.01%
+25.0%
Q2 2022$19,508,000
+124.6%
603,959
+130.1%
0.00%
+100.0%
Q1 2022$8,686,000
-24.5%
262,434
-2.9%
0.00%0.0%
Q4 2021$11,500,000
-3.5%
270,313
+0.5%
0.00%0.0%
Q3 2021$11,919,000
-23.6%
269,006
-2.0%
0.00%
-33.3%
Q2 2021$15,600,000
-25.3%
274,601
-1.6%
0.00%
-25.0%
Q1 2021$20,890,000
-17.3%
279,090
-4.4%
0.00%
-20.0%
Q4 2020$25,247,000
+38.0%
291,830
-2.5%
0.01%
+25.0%
Q3 2020$18,301,000
+44.1%
299,437
-2.0%
0.00%
+33.3%
Q2 2020$12,699,000
+68.3%
305,422
+16.2%
0.00%
+50.0%
Q1 2020$7,547,000
-58.4%
262,770
+4.6%
0.00%
-50.0%
Q4 2019$18,128,000
-54.5%
251,127
-11.6%
0.00%
-60.0%
Q3 2019$39,855,000
-20.7%
284,088
+3.4%
0.01%
-16.7%
Q2 2019$50,280,000
+21.8%
274,620
+5.8%
0.01%
+20.0%
Q1 2019$41,275,000
+95.7%
259,501
+17.9%
0.01%
+66.7%
Q4 2018$21,090,000
-32.2%
220,176
-0.1%
0.01%
-25.0%
Q3 2018$31,125,000
-10.4%
220,349
-0.7%
0.01%
-11.1%
Q2 2018$34,746,000
-56.3%
221,976
-55.0%
0.01%
-57.1%
Q1 2018$79,503,000
+8.7%
493,595
+11.1%
0.02%
+10.5%
Q4 2017$73,157,000
+184.9%
444,158
+7.8%
0.02%
+171.4%
Q3 2017$25,678,000
-21.6%
412,174
+0.2%
0.01%
-22.2%
Q2 2017$32,767,000
+32.1%
411,444
+17.9%
0.01%
+28.6%
Q1 2017$24,802,000
+42.2%
348,970
+2.2%
0.01%
+40.0%
Q4 2016$17,439,000
+23.8%
341,534
+11.6%
0.01%
+25.0%
Q3 2016$14,091,000
+64.8%
305,998
+7.8%
0.00%
+33.3%
Q2 2016$8,550,000
+46.4%
283,797
+55.7%
0.00%
+50.0%
Q1 2016$5,842,000
-33.9%
182,223
+20.1%
0.00%
-33.3%
Q4 2015$8,843,000
+43.8%
151,685
+4.4%
0.00%
+50.0%
Q3 2015$6,148,000
+3.5%
145,271
+78.6%
0.00%0.0%
Q2 2015$5,939,000
+92.0%
81,343
+32.1%
0.00%
+100.0%
Q1 2015$3,093,000
+44.1%
61,594
+5.1%
0.00%0.0%
Q4 2014$2,146,000
+388.8%
58,615
+321.4%
0.00%
Q3 2014$439,00013,9110.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders